[Epidemiology of atrial fibrillation].

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Revista Portuguesa de Cardiologia

• Publication date

  2010-07-01

• Fields of study

  Medicine

• Identifiers
  PMID 21072908
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Incidence, prevalence, and mortality estimates for chronic atrial fibrillation in Turkish adults].

  2008cited by this paper
• Physical Activity and Incidence of Atrial Fibrillation in Older Adults: The Cardiovascular Health Study

  2008cited by this paper
• Prevalence of atrial fibrillation in community-dwelling Japanese aged 40 years or older in Japan: analysis of 41,436 non-employee residents in Kurashiki-city.

  2008cited by this paper
• Low prevalence of atrial fibrillation in community-dwelling Chinese aged 55 years or older in Singapore: a population-based study.

  2008cited by this paper
• Prevalence and prognosis of patients with atrial fibrillation in Japan: a prospective cohort of Shinken Database 2004.

  2008cited by this paper
• An Epidemiological Study on the Prevalence of Atrial Fibrillation in the Chinese Population of Mainland China

  2008cited by this paper
• Trends in Incidence, Risk Factors, and Survival in Symptomatic Lacunar Stroke in Dijon, France, From 1989 to 2006: A Population-Based Study

  2008cited by this paper
• [Prevalence of atrial fibrillation in the Spanish population aged 60 years or more. The PREV-ICTUS study].

  2007cited by this paper
• A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland

  2007cited by this paper
• [Atrial fibrillation: prevalence, risk factors and mortality in a large French population with 15 years of follow-up].

  2007cited by this paper
• Atrial fibrillation in heart failure patients: Prevalence in daily practice and effect on the severity of symptoms. Data from the ALPHA study registry

  2007cited by this paper
• Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.

  2006cited by this paper
• Increased risk of sudden and non-sudden cardiovascular death in patients with atrial fibrillation/flutter following acute myocardial infarction.

  2006cited by this paper
• Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study.

  2006cited by this paper
• Stroke incidence and prevalence in Europe: a review of available data

  2006cited by this paper
• Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence

  2006cited by this paper
• Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis.

  2005cited by this paper
• Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation.

  2005cited by this paper
• Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).

  2005cited by this paper
• Prevalence of and Risk Factors for Atrial Fibrillation in Korean Adults Older than 40 Years

  2005cited by this paper
• Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care

  2005cited by this paper
• The Prevalence of Atrial Fibrillation among Acute Medical Admissions in Kuwait

  2005cited by this paper
• Cardiovascular risk factors, ECG abnormalities and quality of life in subjects with atrial fibrillation

  2005cited by this paper
• Enalapril Decreases the Incidence of Atrial Fibrillation in Patients With Left Ventricular Dysfunction Insight From the Studies Of Left Ventricular Dysfunction (SOLVD) Trials

  2003cited by this paper
• [Permanent atrial fibrillation in heart disease in Spain. The CARDIOTENS study 1999].

  2002cited by this paper
• Use of Irbesartan to Maintain Sinus Rhythm in Patients With Long-Lasting Persistent Atrial Fibrillation: A Prospective and Randomized Study

  2002cited by this paper
• Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

  2001cited by this paper
• [Prevalence of atrial fibrillation in the province of Girona, Spain: the REGICOR study].

  2001cited by this paper
• Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study

  2001cited by this paper
• Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

  1999cited by this paper
• Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study.

  1999cited by this paper
• Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

  1999cited by this paper
• Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.

  1999cited by this paper
• Screening for atrial fibrillation in primary care

  1998cited by this paper
• Prevalence of atrial fibrillation and eligibility for anticoagulants in the community.

  1998cited by this paper
• A 15.5-year follow-up study of stroke in a Japanese provincial city. The Shibata Study.

  1997cited by this paper
• A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project.

  1997cited by this paper
• Atrial fibrillation in elderly patients: prevalence and comorbidity in general practice

  1996cited by this paper
• Prevalence of palpitations, cardiac arrhythmias and their associated risk factors in ambulant elderly.

  1996cited by this paper
• Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators.

  1996cited by this paper
• Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.

  1995cited by this paper
• The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study.

  1995cited by this paper
• Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.

  1994cited by this paper
• Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study).

  1994cited by this paper
• Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.

  1992cited by this paper
• Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

  1991cited by this paper
• Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

  1991cited by this paper
• Atrial fibrillation and mortality in an elderly population.

  1989cited by this paper
• Stroke incidence and risk factors for stroke in Copenhagen, Denmark.

  1988cited by this paper
• Chronic atrial fibrillation--epidemiologic features and 14 year follow-up: a case control study.

  1987cited by this paper
• Study of the prevalence of atrial fibrillation in general practice patients over 65 years of age.

  1987cited by this paper
• Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

  1987cited by this paper

• Umbrella review of anticoagulation strategies for secondary prevention of cardioembolic stroke in atrial fibrillation: efficacy, safety, and knowledge gaps

  2025cites this paper
• Impact of atrial fibrillation on outcomes in stroke patients with tandem occlusions treated with thrombectomy: A multicentre study

  2025cites this paper
• The Effects of Warfarin and Novel Oral Anticoagulants on Depression and Anxiety in Patients with Non-Valvular Atrial Fibrillation.

  2025cites this paper
• An Investigation of the Correlation Between the ABCB1 Rs4728709 Gene Polymorphism with Rivaroxaban Response and Bleeding Events in Patients with Atrial Fibrillation from Tthe Southern Region of Iraq

  2025cites this paper
• Patients’ characteristics and six-month outcomes of patients with atrial fibrillation in Kenya: a retrospective observational cohort study from the National Cardiovascular Registry

  2025influential citation
• VALUE OF HIGH SENSITIVITY C-REACTIVE PROTEIN AND NT-PROBNP LEVEL IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION

  2024cites this paper
• UNRAVELLING ATRIAL FIBRILLATION AETIOLOGY AND ANTICOAGULATION TRENDS IN STROKE. WHERE DO WE STAND? A STUDY FROM NORTHERN PAKISTAN.

  2024cites this paper
• Coronary microvascular dysfunction, arrythmias, and sudden cardiac death: A literature review

  2024cites this paper
• Burden of Disease and Cost of Illness of Overweight and Obesity in Portugal

  2024cites this paper
• Prevalence of Atrial Fibrillation in Semiurban Nepal: Result From a Community-Based Cross-Sectional Screening

  2024influential citation
• Blood pressure, hypertension and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies

  2023cites this paper
• Hybrid strategies for stand-alone surgical ablation of atrial fibrillation

  2023cites this paper
• The Relationship between Hyperuricemia and Echocardiographic Parameters in Patients with Chronic Atrial Fibrillation

  2023cites this paper
• Tratamiento de la fibrilación auricular en el servicio de urgencias: una revisión práctica de la literatura

  2023cites this paper
• Multicomponent Organization Analysis in Spatial Domains of Atrial Fibrillation

  2023cites this paper
• Clinicians’ adherence to guidelines for the preoperative management of direct oral anticoagulants in a tertiary hospital: a retrospective study

  2023cites this paper
• Outcomes of Patients With Atrial Fibrillation Following Thrombectomy for Stroke

  2023cites this paper
• Glucagon-Like Peptide-1 Protects Against Atrial Fibrillation and Atrial Remodeling in Type 2 Diabetic Mice

  2023cites this paper
• Standardizing periprocedural anticoagulation management: a stewardship initiative

  2023cites this paper
• Use of Non-Vitamin K-Dependent Oral Anticoagulants in Elderly and Fragile Patients with Atrial Fibrillation

  2023cites this paper
• Loss of the Atrial Fibrillation-Related Gene, Zfhx3, Results in Atrial Dilation and Arrhythmias

  2023cites this paper
• Early Echocardiographic Predictors for Atrial Fibrillation Propensity: The Left Atrium Oracle

  2022cites this paper
• Remodeling and Fibrosis of the Cardiac Muscle in the Course of Obesity—Pathogenesis and Involvement of the Extracellular Matrix

  2022cites this paper
• Incidence of Aphasia in Ischemic Stroke

  2022cites this paper
• Inter-patient detection of atrial fibrillation in short ECG segments based on LSTM network with multiple input layers

  2022cites this paper
• Incidence of nonvalvular atrial fibrillation and oral anticoagulant prescribing in England, 2009 to 2019: A cohort study

  2022cites this paper
• The Association between Treatment with Bisphosphonates and the Risk of Atrial Fibrillation: A Meta-Analysis of Observational Studies

  2022cites this paper
• Radiofrequency ablation for treatment of atrial fibrillation with the use of intracardiac echocardiography versus without intracardiac echocardiography: A meta‐analysis of observational and randomized studies

  2022cites this paper
• Identification of Patients with Potential Atrial Fibrillation during Sinus Rhythm Using Isolated P Wave Characteristics from 12-Lead ECGs

  2022cites this paper
• The Patient Pathway Review for Atrial Fibrillation

  2022cites this paper
• Clinical variables for predicting type-1 and type-2 non-ST segment elevation myocardial infarction in those presenting with ischemic symptoms

  2022cites this paper
• Comparison of traditional radiofrequency ablation and high-power short-duration ablation in the treatment of atrial tachyarrhythmias

  2022cites this paper
• Atherosclerosis and Atrial Fibrillation: Double Trouble

  2022influential citation
• Лабораторные предикторы клинических исходов у пациентов с фибрилляцией предсердий DOI:10.20996/1819-6446-2021-04-14. Laboratory predictors of clinical outcomes in patients with

  2021cites this paper
• Comparative study of adverse drug reactions among direct-acting oral anticoagulants and vitamin K antagonists using the EudraVigilance database

  2021cites this paper
• The Association between Physical Activity and Cardiovascular Implantable Electronic Device-Detected Atrial High Rate Episodes.

  2021cites this paper
• The prevalence and predictors of Stroke among atrial fibrillation patients attending at Gondar University Referral Hospital, Northwest Ethiopia

  2021cites this paper
• Stress-driven cardiac calcium mishandling via a kinase-to-kinase crosstalk

  2021cites this paper
• 12-Month Single-Procedure Outcomes after Atrial Fibrillation Catheter Ablation in Phramongkutklao Hospital: A Single Center 10-Year Experience

  2021cites this paper
• OP-EHEA210428_online 4126..4138

  2021cites this paper
• The Sensitivity of The Heart Rate Detection for Atrial Electrograms Signal

  2021cites this paper
• Compliance a kvalita života u pacientů s antikoagulační léčbou: první výsledky pilotní studie

  2021influential citation
• Exosomes in atrial fibrillation: therapeutic potential and role as clinical biomarkers

  2021cites this paper
• Antithrombotic Therapy in Complex Percutaneous Coronary Intervention Patients Requiring Chronic Anticoagulation

  2021cites this paper
• Atrial Fibrillation as a Predictor of In-Hospital Outcome in Patients with Acute Coronary Syndrome Treated by Primary Percutaneous Coronary Intervention

  2021cites this paper
• Alterations of housekeeping proteins in human aged and diseased hearts

  2021cites this paper
• Safety and Efficacy of Rivaroxaban and Apixaban in Patients with Increased Body Mass: a Systematic Review

  2021cites this paper
• The comparison of Kardia Mobile and Hartmann Veroval 2 in 1 in detecting first diagnosed atrial fibrillation

  2021cites this paper
• Atrial fibrillation: the impact of anxiety and depression on patients' needs.

  2021cites this paper
• News on angiotensin II and atrial fibrillation : from the molecular to the pathophysiological.

  2021cites this paper
• Serine-threonine protein phosphatase regulation of Cx43 dephosphorylation in arrhythmogenic disorders.

  2021cites this paper
• Atrial conduction time associated predictors of recurrent atrial fibrillation

  2021cites this paper
• TIME IN THERAPEUTIC RANGE (TTR) IN ATRIAL FIBRILLATION WITH WARFARIN THERAPY IN SEMARANG, INDONESIA

  2021cites this paper
• β-Blockade for Patients with Hypertension, Ischemic Heart Disease or Heart Failure: Where are We Now?

  2021influential citation
• Modifiable Risk Factors and Atrial Fibrillation: the Quest for a Personalized Approach.

  2021cites this paper
• VHRM_A_285907 337..348

  2021influential citation
• Identifying the key microRNAs implicated in atrial fibrillation.

  2021cites this paper
• Anticoagulation in Very Old Patients with Atrial Fibrillation (AVOPA): A Descriptive Observational Study

  2021cites this paper
• The effect of a case-finding app on the detection rate of atrial fibrillation compared with opportunistic screening in primary care patients: protocol for a cluster randomized trial

  2021cites this paper
• Atrial Fibrillation One of Hidden Causes of Subclinical Stroke: Case-Control Study

  2021cites this paper
• Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option

  2021influential citation
• терапии фибрилляции Changes in Antithrombotic Therapy of in the Hospital in 2011-2012 and 2016-2017

  2020cites this paper
• Incidence of Atrial Fibrillation in Hemodialysis Patients

  2020cites this paper
• Identification of microRNAs enriched in exosomes in human pericardial fluid of patients with atrial fibrillation based on bioinformatic analysis

  2020cites this paper
• Cost‐effectiveness analysis of dabigatran, rivaroxaban and warfarin in the prevention of stroke in patients with atrial fibrillation in China

  2020cites this paper
• Características clínico-epidemiológicas de la fibrilación auricular en pacientes de 65 años o más diagnosticados en Atención Primaria

  2020influential citation
• How to Manage Atrial Fibrillation in the Emergency Department: a Critical Appraisal

  2020cites this paper
• Improvement in Left Atrial Strain among Patients Undergoing Percutaneous Left Atrial Appendage Closure

  2020cites this paper
• New-onset atrial fibrillation during COVID-19 infection predicts poor prognosis.

  2020cites this paper
• A Prospective Registry of Atrial Fibrillation Ablation with the Ablation Index Technology: Rationale and Study Design

  2020cites this paper
• Paroxysmal and non-paroxysmal atrial fibrillation: does the arrhythmia type influence thromboembolic risk?

  2020cites this paper
• Epicardial Fat Volume as a New Imaging-Based Feature Associated with Risk of Recurrence after Pulmonary Veins Ablation in Atrial Fibrillation

  2020influential citation
• THE PRE-DIAGNOSIS SYMPTOM EXPERIENCE OF PATIENTS WITH ATRIAL FIBRILLATION

  2019influential citation
• 4D Cardiac Activation Wave Mapping in In Vivo Swine Model using Acoustoelectric Imaging

  2019cites this paper
• Hyperuricemia as a Risk Factor for Atrial Fibrillation Due to Soluble and Crystalized Uric Acid

  2019cites this paper
• Heparin Bridging Therapy for Patients on Chronic Oral Anticoagulants in Periprocedural Settings

  2019cites this paper
• Expression profile of circulating lncRNAs in patients with atrial fibrillation

  2019cites this paper
• Systematic Evaluation of Efficacy and Safety of Acupuncture Treatment for Patients with Atrial Fibrillation

  2019cites this paper
• Characteristics of Atrial Fibrillation Patients with a Family History of Atrial Fibrillation.

  2019cites this paper
• Prevalence and risk factors for atrial fibrillation and its anticoagulant requirement in adults aged ≥40 in Jimma Town, Southwest Ethiopia: A community based cross-sectional study

  2019cites this paper
• Pharmacological Cardioversion of Acute Atrial Fibrillation

  2019cites this paper
• Oral Manifestations of Systemic Diseases and Their Treatments

  2019cites this paper
• Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant.

  2019cites this paper
• Screening for Atrial Fibrillation in Zambia’s Western Province

  2019cites this paper
• Screening for Atrial Fibrillation : a European Heart Rhythm Association ( EHRA ) consensus document endorsed by the Heart Rhythm Society ( HRS ) , Asia Pacific Heart Rhythm Society ( APHRS ) , and Societad Latinoamericana de Estimulation

  2018cites this paper
• The stress kinase JNK regulates gap junction Cx43 gene expression and promotes atrial fibrillation in the aged heart.

  2018cites this paper
• Peut-on prédire l'absence de récidive de fibrillation atriale sur la base des caractéristiques de la procédure d'isolation des veines pulmonaires par cryoballonnet ?

  2018cites this paper
• Management of newly diagnosed atrial fibrillation in an outpatient clinic setting—patient's perspectives and experiences

  2018cites this paper
• Experiencia clínica en monitorización cardiaca extendida con el sistema inalámbrico satelital tipo SEEQ

  2018cites this paper
• Prognostic impact of atrial fibrillation in cardiogenic shock complicating acute myocardial infarction: a substudy of the IABP-SHOCK II trial

  2018cites this paper
• Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE).

  2018cites this paper
• Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad

  2018cites this paper
• Assessment of the clinical efficacy of the heart spectrum blood pressure monitor for diagnosis of atrial fibrillation: An unblinded clinical trial

  2018cites this paper
• Epidemiology of atrial fibrillation

  2018cites this paper
• Comparison of cryoballoon and radiofrequency ablation techniques for atrial fibrillation: a meta-analysis

  2018cites this paper
• Predictors of de novo atrial fibrillation in a non-cardiac intensive care unit

  2018cites this paper
• Association Between Blood Lipid Profiles and Atrial Fibrillation: A Case-Control Study

  2018cites this paper
• Atrial Fibrillation in Hypertension: Patients’ Characteristics

  2018cites this paper
• Diabetes mellitus, blood glucose and the risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies.

  2018cites this paper
• Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulaci (cid:2) on Card (cid:2) ıaca y Electrofisiolog (cid:2) ıa (SOLAECE)

  2017cites this paper